Neuronetics Sees FY2026 Sales $160.000M-$166.000M vs $164.167M Est

Benzinga Newsdesk www.benzinga.com Positive 71.5%

Neg 0% Neu 0% Pos 71.5%

Neuronetics (NASDAQ:STIM) sees FY2026 sales of $160.000 million-$166.000 million vs $164.167 million analyst estimate.

Comments

No comments yet. Be the first!